Dechra Pharmaceuticals
#2371
Rank
$5.44B
Marketcap
United Kingdom
Country
Mr. Ian D. Page (CEO, MD & Exec. Director)
Mr. Paul Nicholas Sandland MAAT, FCCA (CFO & Exec. Director)
Dr. Anthony Gerard Griffin (MD of Dechra Veterinary Products for Europe & Exec. Director)
Summary
History
The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists. It was first listed on the London Stock Exchange in 2000. In 2007 it bought VetXX, a Danish veterinary products business, for £62 million. In 2010 it purchased Florida-based DermaPet for US$64 million and Sussex-based Genitrix for £5 million.It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.
Mission
Vision
Key Team
Mr. Patrick Meeus (Group Scientific Officer)
Ms. Katy Clough (Group HR Director)
Mr. Mike Eldred (Pres of North America)
Ms. Melanie Hall (Company Sec.)
Recognition and Awards
References
Mr. Ian D. Page (CEO, MD & Exec. Director)
Mr. Paul Nicholas Sandland MAAT, FCCA (CFO & Exec. Director)
Dr. Anthony Gerard Griffin (MD of Dechra Veterinary Products for Europe & Exec. Director)